The system subordinates the pharmacist's choice to that of the clinician

October 11, 2021 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

A report contained claims it is inappropriate but it is exactly how the system is designed to work - financial incentives to encourage the dispensing of biosimilars are contingent on and subordinated to clinical judgement. …

Subscribe now to continue reading.

Latest Video

Health Department clarifies PBAC plan after confusion over paediatric access to biologics
December 10, 2025 - Latest News
If this was the plan, why wasn't it included in the response to questions last week?
December 10, 2025 - Latest News
Immutep strikes major licensing deal with Dr. Reddy’s to commercialise novel cancer immunotherapy
December 9, 2025 - Australian Biotech
Pfizer’s high-stakes sprint to build momentum in century-defining market
December 11, 2025 - Latest News
Mayne Pharma rejects Cosette’s attempt to terminate scheme deal
December 10, 2025 - Latest News

The system subordinates the pharmacist's choice to that of the clinician

This is a preview of subscriber content

Latest Video

Most Read

Health Department clarifies PBAC plan after confusion over paediatric access to biologics

If this was the plan, why wasn't it included in the response to questions last week?

Immutep strikes major licensing deal with Dr. Reddy’s to commercialise novel cancer immunotherapy

Pfizer’s high-stakes sprint to build momentum in century-defining market

Mayne Pharma rejects Cosette’s attempt to terminate scheme deal

New Stories

Medicines Australia gains a new voice with Vertex joining the association

BMS marks 70 years in Australia with renewed commitment to innovation and access

Opportunity cost is a moral and ethical question when it involves travel, tickets, or treating sick children

Pfizer’s high-stakes sprint to build momentum in century-defining market

Mayne Pharma rejects Cosette’s attempt to terminate scheme deal

TGA clears the way for LTR Pharma’s Phase 2 Study of SPONTAN

OncoSil announces first UK patient treated with its pancreatic cancer treatment

Sign In

The system subordinates the pharmacist's choice to that of the clinician

This is a preview of subscriber content

Latest Video

Most Read

Health Department clarifies PBAC plan after confusion over paediatric access to biologics

If this was the plan, why wasn't it included in the response to questions last week?

Immutep strikes major licensing deal with Dr. Reddy’s to commercialise novel cancer immunotherapy

Pfizer’s high-stakes sprint to build momentum in century-defining market

Mayne Pharma rejects Cosette’s attempt to terminate scheme deal

Follow Us

New Stories

Medicines Australia gains a new voice with Vertex joining the association

BMS marks 70 years in Australia with renewed commitment to innovation and access

Opportunity cost is a moral and ethical question when it involves travel, tickets, or treating sick children

Pfizer’s high-stakes sprint to build momentum in century-defining market

Mayne Pharma rejects Cosette’s attempt to terminate scheme deal

TGA clears the way for LTR Pharma’s Phase 2 Study of SPONTAN

OncoSil announces first UK patient treated with its pancreatic cancer treatment